Company Monitoring Page for AbbVie

latest headlines for company on cafepharma

AbbVie inks licensing deal to boost Mavyret access in nearly 100 countries
Fierce Pharma
Tue, 11/13/18 - 10:24 pm
Tags:
AbbVie, hepatitis C, Mavyret, Medicines Patent Pool
Boehringer Cites ‘Massive’ Number of Patents in Humira Biosimilar Suit
RAPS.org
Fri, 11/9/18 - 11:34 am
Tags:
Boehringer Ingelheim, AbbVie, Humira, patents, biosimilars
AbbVie hatches plans for a major new R&D hub close to its partners in Bay Area's buzzy Oyster Point
Endpoints
Thu, 11/8/18 - 12:09 pm
Tags:
AbbVie, San Francisco, Oyster Point, biotech
Bristol-Myers Squibb snags quick Empliciti combo nod in multiple myeloma
Fierce Pharma
Thu, 11/8/18 - 09:41 am
Tags:
Bristol-Myers Squibb, AbbVie, Empliciti, FDA, Multiple Myeloma, Celgene, Pomalyst
AbbVie staves off 6th Humira biosimilar in US
Biopharma Dive
Wed, 11/7/18 - 10:44 pm
Tags:
AbbVie, Humira, biosimilars, Momenta Pharmaceuticals
Excellent quarter from AbbVie, but market still skeptic about pipeline
GoinPharma
Sun, 11/4/18 - 02:50 pm
Tags:
AbbVie, earnings, Imbruvica
AbbVie Follows Trend of Big Pharma Setting Office-Labs in Biotech Clusters
BioSpace
Fri, 11/2/18 - 07:59 pm
Tags:
AbbVie, San Francisco, biotech clusters, Bay Area
AbbVie says global Humira market eroding faster than expected
BioCentury
Fri, 11/2/18 - 07:55 pm
Tags:
AbbVie, Humira
AbbVie lifts profit target after cancer drug powers quarterly beat
Yahoo/Reuters
Fri, 11/2/18 - 09:26 am
Tags:
AbbVie, earnings
Roche and AbbVie Push Towards First-Line CLL Treatment
BioSpace
Thu, 11/1/18 - 11:28 am
Tags:
Roche, Genentech, AbbVie, clinical trials, Venclexta, Gazyva, CLL, chronic lymphocytic leukemia
Novartis wins US nod for Humira biosimilar, but focus now on Europe
Biopharma Dive
Wed, 10/31/18 - 07:09 pm
Tags:
Novartis, Hyrimoz, biosimilars, Humira, AbbVie, FDA
Ready to Roll! Ten Q3 Biotech Earnings Reports to Watch Next Week
BioSpace
Sat, 10/27/18 - 12:16 pm
Tags:
BrainStorm Cell Therapeutics, Allergan, Pfizer, Clovis Oncology, Acorda Therapeutics, Takeda, Agios Pharmaceuticals, Shire, Teva Pharmaceutical, AbbVie
AbbVie Takes Aim at Vertex Pharmaceuticals Incorporated
Motley Fool
Sat, 10/27/18 - 11:55 am
Tags:
AbbVie, Vertex Pharmaceuticals, cystic fibrosis
Abbott, AbbVie settle TriCor marketing case for $25 million
Yahoo/Reuters
Sat, 10/27/18 - 11:38 am
Tags:
Abbott Labs, AbbVie, kickbacks, TriCor
AbbVie’s CLL drug Venclyxto too expensive for NHS, says NICE
Pharmaforum
Fri, 10/26/18 - 09:54 am
Tags:
NICE, AbbVie, Venclyxto, Roche, Rituxan/MabThera, CLL
AbbVie Takes Over Galapagos Cystic Fibrosis Collaboration Instead of Walking Away
BioSpace
Thu, 10/25/18 - 11:35 am
Tags:
AbbVie, Galapagos, cystic fibrosis
AbbVie rheumatoid arthritis drug succeeds in late stage trial
Yahoo/Reuters
Tue, 10/23/18 - 10:40 am
Tags:
AbbVie, clinical trials, rheumatoid arthritis, Upadacitinib
Battle Over Humira Begins in Europe as 5-Year Wait Begins in US
RAPS.org
Mon, 10/22/18 - 05:17 pm
Tags:
Europe, AbbVie, Humira, Amgen, Samsung Bioepis, Mylan Labs, Novartis, Sandoz, Fresenius Kabi, Boehringer Ingelheim
AbbVie CFO Chase spearheaded its Abbott spinoff and Imbruvica buy—and now he's retiring
Fierce Pharma
Fri, 10/19/18 - 11:13 pm
Tags:
AbbVie, Abbott, Imbruvica
AbbVie wards off another Humira biosim challenger with Fresenius Kabi settlement
Fierce Pharma
Thu, 10/18/18 - 11:29 pm
Tags:
Humira, AbbVie, Fresenius Kabi, Europe

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.